logo
‘It could have sat on your shoulder': Scientists discover North America's oldest pterosaur

‘It could have sat on your shoulder': Scientists discover North America's oldest pterosaur

CTV News12-07-2025
An artist's reconstruction of the fossilized landscape, plants and animals found preserved in a remote bonebed in Petrified Forest National Park in Arizona. (Illustration by Brian Engh)
A team led by the Smithsonian has discovered North America's oldest known pterosaur—a small, seagull-sized flying reptile that lived more than 200 million years ago in what is now Arizona.
According to the report published in Proceedings of the National Academy of Sciences, the fossil was found in a remote part of Petrified Forest National Park. It includes part of the animal's jaw and a wing bone, dating back to nearly 209 million years ago, making it the earliest known pterosaur from the continent.
'There are two other Triassic pterosaur fossils from the North American continent, one from Greenland and one from Utah, but they're both younger than the one we found,' Ben Kligman, the study's lead author and a postdoctoral fellow at the Smithsonian's National Museum of Natural History, said in a video interview with CTVNews.ca.
The new species is named Eotephradactylus mcintireae, meaning 'ash-winged dawn goddess,' referring to the volcanic ash that helped preserve it in an ancient riverbed.
'The animal itself would have been the size of a small seagull, so it could have sat on your shoulder,' Kligman said adding that it likely fed on armoured fish in the river system it once flew over.
pterosaur
Kay Behrensmeyer, curator of vertebrate paleontology at the Smithsonian's National Museum of Natural History, in Petrified Forest National Park documenting the geology of a bonebed in 2023.
'The teeth in the jaw of this pterosaur … all are worn down,' he explained. 'It means that this pterosaur was eating something with a hard skeleton or hard bony parts, and the fish that were living in this river system … would be covered by an armoured skin.'
The find sheds light on a time just before a mass extinction wiped out three-quarters of the world's species and set the stage for dinosaurs to dominate.
The fossil was uncovered with more than 1,200 other specimens, including bones from ancient amphibians, one of the world's oldest turtles and a crocodile relative.
Most early pterosaur fossils have been found in Europe and are flattened by pressure from layers of ocean sediment, but the Arizona discovery was preserved in three dimensions, allowing scientists to study fine details like tooth placement and replacement teeth growing inside the jaw.
pterosaur
Ben Kligman, a Peter Buck Postdoctoral Fellow and paleontologist at the Smithsonian's National Museum of Natural History, quarrying a bonebed in Arizona's Petrified Forest National Park in 2025.
'(They are) animals that could fly, so their bones are oftentimes hollow, and they are difficult to collect,' Kligman said. 'If you have a tiny two-centimetres-long little hollow bone, it's really easy for it to break apart … and it's hard to even recognize the fossil.'
Kligman says similar fossils are likely across the world because pterosaurs could fly, so they didn't have barriers to their dispersal.
He hopes the modern scanning techniques that his team used can open the door for more discoveries in similar riverbed deposits.
'We're hoping through showing a methodology for finding, collecting, preparing and then CT scanning these bones, (we can) open a pathway for us and other researchers to reexamine these Triassic river deposits and hopefully find more pterosaurs.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pop is in the spotlight yet again. This time, for its ability to disrupt gut bacteria and immunity
Pop is in the spotlight yet again. This time, for its ability to disrupt gut bacteria and immunity

National Post

time5 hours ago

  • National Post

Pop is in the spotlight yet again. This time, for its ability to disrupt gut bacteria and immunity

Pop has been a hot topic over the past few weeks. First, U.S. President Donald Trump waded into MAHA — Make America Healthy Again — waters by saying Coca-Cola was swapping high-fructose corn syrup for cane sugar. 'It's just better!' he posted on social media. (Health experts say it's not. There's no nutritional difference between the two.) Article content Drinking pop has long been linked to adverse health effects, such as obesity, Type 2 diabetes and heart disease. Added sugars (whatever their source) are the primary culprit, yet 'diet sodas, which have been found to increase hunger and disrupt metabolism, are not any better,' according to UCLA Health. A new study suggests another pop-consumption concern: sugary drinks disrupt gut bacteria and immunity. Article content Article content But it's not all doom and gloom, say researchers from the Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology. The study published in Nature Communications found that though drinking pop sweetened with white sugar alters the DNA of gut bacteria and affects the immune system, once sugar consumption stops, the impacts are reversible. Article content Article content 'Gut bacteria are important members of the microbial community within our body, i.e., the microbiome. These bacteria, which have co-evolved with humans for generations, are so essential to human health in general and to the development of the immune system in particular that we cannot function without them,' says a press release about the research. Studies have shown that diet influences microbiome composition and overall functionality, write the researchers, led by professor Naama Geva-Zatorsky and Ph.D. student Noa Gal-Mandelbaum. In contrast, research on the impact of what we eat on the functionality of specific gut bacteria is 'relatively scarce.' Article content Article content The current research builds on a previous study by the Geva-Zatorsky Lab, which identified DNA inversions ('rapid genetic switches') as one way gut bacteria respond to and protect themselves when facing environmental changes. To understand how dietary factors affect these inversions, the study focused on Bacteroides thetaiotaomicron. Article content Article content The researchers say that this 'prominent gut member' plays a role in preventing gut inflammation, preserving its mucus layer and protecting the body from pathogens. By studying the effects of different dietary components on the bacteria's DNA, in vitro, in mice and in humans, the researchers found that white sugar consumption created DNA inversions, which impacted the immune system. Article content In a social media post, Technion said, 'This discovery highlights the deep connection between our diet, microbiome and health — and opens the door to personalized nutrition for a stronger immune system.' Article content

Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations

National Post

time9 hours ago

  • National Post

Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations

Article content SEATTLE — Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, a specialist investor in the life science tools and services industry. Article content The newly raised capital will enable Pluristyx to expand inventory with new clinical grade cell lines incorporating Pluristyx's proprietary FailSafe® and iACT™ engineering and hypoimmune genetic edits in its best-in-class, polyclonal, synthetic RNA reprogramed iPSCs. These proprietary cells are specifically designed to support making next-generation genetically engineered, stem cell-derived therapies and support uniquely safe, effective, and scalable living medicines. The funding will also support Pluristyx's recently launched PluriForm ™ kit, which provides researchers with streamlined tools for generating organoids and other complex test systems. Article content 'We are incredibly excited for the successful close of this round and gratified to have industry leaders and peers validate our vision with their investment,' said Benjamin Fryer, PhD, CEO of Pluristyx. 'The support from our Seattle area neighbor, BioLife Solutions, and continued support from our colleagues at BroadOak Partners will allow us to manufacture, commercialize, and distribute our innovative solutions and help our customers solve critical industry challenges.' Article content Roderick de Greef, BioLife's Chairman and CEO, remarked, 'We have known and worked with the founding team at Pluristyx for many years, and have a great deal of respect for their scientific expertise in cell therapy. Their recent development of an iPSC-based biological assay for organoid manufacturing dovetails with our interest in exploring biological assays more broadly as a product portfolio adjacency.' Article content 'We are excited to continue our support of Dr. Fryer and the entire Pluristyx team,' said Daniel Friedman, Principal at BroadOak Capital Partners. 'Pluristyx is differentiated by its suite of proprietary technologies that directly address some of the most critical scientific challenges of the iPSC field.' Article content iPSCs are unique tools and building blocks for medicines. In addition to applications for innovative new toxicology, safety, and efficacy assays to replace animal models, Pluristyx's products are the ideal universal raw material to produce living medicines to cure currently untreatable diseases. This strategic investment will enable Pluristyx to be the industry leader offering the highest quality stem cells available anywhere. Article content About BioLife Solutions Article content BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit or follow BioLife on LinkedIn and X. Article content About BroadOak Capital Partners Article content BroadOak Capital Partners is a boutique financial institution that provides direct investment and investment banking services to companies in the life science tools, diagnostics, and biopharma services sectors. BroadOak has led or participated in investments in over 70 companies across the life sciences industry. For more information, visit Article content Pluristyx is dedicated to enabling the development of next-generation cell-based tools and therapies. PluriKit™, PluriForm™ Organoids, and PluriBank™ stem cells incorporating safety and tolerance features like FailSafe®, iACT™, and hypoimmune engineering streamline developers' path to the clinic and approval. Pluristyx's iPSC lines, backed by an FDA registered drug master file, with platform genetic engineering are available 'off-the-shelf' along with comprehensive support services to accelerate the creation of novel diagnostics, screening and safety testing, and curative treatments. For more information, visit Article content Article content Article content Article content

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store